Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-007498
Filing Date
2022-02-23
Accepted
2022-02-23 20:00:22
Documents
1
Period of Report
2022-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4128
  Complete submission text file 0000899243-22-007498.txt   5472
Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Issuer) CIK: 0001745020 (see all company filings)

EIN.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SELECTA BIOSCIENCES, INC. 480 ARSENAL WAY WATERTOWN MA 02472
Business Address
Dahms Bradford D. (Reporting) CIK: 0001787307 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40869 | Film No.: 22665844